Severe necrotizing myopathy subsequent to Merkel cell carcinoma;Myopathie nécrosante sévère consécutive à un carcinome à cellules de Merkel

Annales de Dermatologie et de Venereologie

Volumn 138, Issue 2, 2011, Pages 130-134

  Hocar, O ^a   Poszepczynska Guigne E ^a   Faye, O ^a   Wechsler, J ^a   Bagot, M ^a   Buffard, V ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Anti Hu antibodies; Merkel cell carcinoma; Necrotizing myopathy; Neuroendocrine cutaneous carcinoma; Paraneoplastic syndrome

Indexed keywords

CARBOPLATIN; CORTICOSTEROID DERIVATIVE; ETOPOSIDE; HU ANTIBODY; IMMUNOGLOBULIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; MERKEL CELL TUMOR; MYOPATHY; NECROTIZING MYOPATHY; NEUROLOGIC EXAMINATION; PARANEOPLASTIC SYNDROME; TUMOR BIOPSY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTOANTIBODIES; BIOPSY; CARCINOMA, MERKEL CELL; COMBINED MODALITY THERAPY; FATAL OUTCOME; FEMALE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; IMMUNIZATION, PASSIVE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; NECROSIS; PARANEOPLASTIC SYNDROMES; SKIN; SKIN NEOPLASMS;

EID: 79951960309     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2010.11.008     Document Type: Article

References (15)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972;105:107-10.
2. Tang CK, Toker C. Trabecular carcinoma of the skin. An ultrastructural study. Cancer 1978;42:2311-21.
3. Carpentier O, Carrotte-Lefebvre I, Patenotre P, Mirabel X, Delaporte E, Piette F. Carcinomes neuroendocrines cutanés primitifs ou tumeurs de Merkel. Aspects cliniques et thérapeutiques chez 22 patients. Presse Med 2002;31:735-9.
4. Foulongne V, Kluger N, Dereure O, Brieu N, Guillot B, Segondy M. Merkel cell polyoma-virus in patients with Merkel cell carcinoma France. Emerg Infect Dis 2008;9:1491-3.
5. Eggers SD, Salomao DR, Dinapoli RP, Vernino S. Paraneoplastic and metastatic neurologic complications of Merkel cell carcinoma. Mayo Clin Proc 2001;76:327-30. (Pubitemid 32206949)
6. Cartalat-Carel S, Camdessanché JP, Antoine JC, Honnorat J. Syndromes neurologiques paranéoplasiques. EMC-Neurologie 2005;2:191-203.
7. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40. (Pubitemid 39005770)
8. Antoine JC, Camdessanché JP. Syndromes neurologiques paranéoplasiques. Presse Med 2007;36:1418-26.
9. Gaillard N, Charif M, Carlander B, Pujol JL, Touchon J. Traitement par chimiothérapie d'un syndrome neurologique paranéoplasique anti-Hu sans cancer actif associé. Rev Neurol (Paris) 2006;162:862-5. (Pubitemid 44359175)
10. Greenlee JE, Steffens JD, Clawson SA, Hill K, Dalmau J. Anti-Hu antibodies in Merkel cell carcinoma. Ann Neurol 2002;52:111-5. (Pubitemid 34693754)
11. Lopez MC, Pericay C, Agusti M, Martinez-Gallo M, Bordes R, Gelpi C. Merkel cell carcinoma associated with a paraneoplastic neurological syndrome. Histopathology 2004;44:628-9. (Pubitemid 38845112)
12. Levin MI, Mozaffar T, Al-Lozi MT, Pestronk A. Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology 1998;50:764-7.
13. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003;349:1543-54. (Pubitemid 37255041)
14. Gill S, Murray N, Dalmau J, Thiessen B. Paraneoplastic sensory neuronopathy and spontaneous regression of small cell lung cancer. Can J Neurol Sci 2003;30:269-71. (Pubitemid 37064526)
15. Keime-Guibert F, Graus F, Broet P, Rene R, Molinuevo JL, Ascaso C, et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 1999;53:1719-23. (Pubitemid 29530345)